Subject: ADMD Execs Update on Progress with FDA on RadioGel™ and Exciting Future Applications

SCV Client Spotlight
BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement., Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.
Facebook Twitter YouTube
ADMD Execs Update on Progress with FDA on RadioGel™ and Exciting Future Applications
Hot Stock to WatchHot Stock to Watch

Company: Advanced Medical Isotope Corporation (Pink Sheets: ADMD)


Price: 0.0032

Change (%): + 0.0006 (22.31)

Volume: 7,875,000
ADMD Chart

Founder, CEO and Chairman James C. Katzaroff and Dr. Darrell Fisher, Primary Inventor of RadioGel™, Provide Update on Advances in a New Audio Interview at

AUSTIN, Texas, Aug. 03, 2016 (GLOBE NEWSWIRE) --, Inc. (SCV) and Advanced Medical Isotope Corporation (or "AMI") (OTC:ADMD), ( a late stage development company engaged in the development of brachytherapy devices for therapeutic applications, announced today that a new audio interview with the Company is now available. The interview can be heard at

Founder, CEO and Chairman James C. Katzaroff and Dr. Darrell Fisher, Primary Inventor of RadioGel™ called in to, Inc. to go over the advances the Company has made with its RadioGel™, updates on potential uses, and where AMI stands in the testing and FDA process.

"I am most pleased that the inventor, Dr. Fisher, is able to clearly articulate the features that make RadioGel such a unique and novel medical device in the war against cancer. We are excited and look forward to keeping our shareholders apprised of our progress," stated Katzaroff.

Continue Reading

Like Us on FacebookFollow Us on Twitter

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks